dc.contributor.author | Behnes, Michael | |
dc.contributor.author | Akin, Ibrahim | |
dc.contributor.author | Yildiz, Mustafa | |
dc.contributor.author | Oksen, Dogac | |
dc.date.accessioned | 2021-03-04T14:16:17Z | |
dc.date.available | 2021-03-04T14:16:17Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Yildiz M., Oksen D., Behnes M., Akin I., "Contribution and Value of Biomarkers in Acute Aortic Syndromes", CURRENT PHARMACEUTICAL BIOTECHNOLOGY, cilt.18, sa.6, ss.495-498, 2017 | |
dc.identifier.issn | 1389-2010 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_80abb513-593e-4fa7-aa4a-bf53bcc91a8c | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/87751 | |
dc.identifier.uri | https://doi.org/10.2174/1389201018666170615081727 | |
dc.description.abstract | Background: Acute aortic syndromes, being mostly underdiagnosed due to unspecific symptoms, are associated with high morbidity and mortality. Diagnosis carried out by transesophageal echocardiography, computed tomography and magnetic resonance imaging. However, there are lots of biochemical assays being investigated, but none of them used reliably to identify acute aortic syndromes. Biomarkers could accelerate the diagnostic time with cost effective way and could get place in definitive diagnostic algorithm of acute aortic syndrome. This review aims to identify contribution and value of biomarkers in acute aortic syndromes. | |
dc.language.iso | eng | |
dc.subject | Molecular Biology | |
dc.subject | Drug Discovery | |
dc.subject | Aging | |
dc.subject | General Biochemistry, Genetics and Molecular Biology | |
dc.subject | General Pharmacology, Toxicology and Pharmaceutics | |
dc.subject | Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | |
dc.subject | Biochemistry | |
dc.subject | Structural Biology | |
dc.subject | Pharmacy | |
dc.subject | Drug Guides | |
dc.subject | Life Sciences | |
dc.subject | Health Sciences | |
dc.subject | Pharmacology (medical) | |
dc.subject | BİYOKİMYA VE MOLEKÜLER BİYOLOJİ | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Eczacılık | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Sitogenetik | |
dc.subject | Temel Bilimler | |
dc.subject | Biochemistry, Genetics and Molecular Biology (miscellaneous) | |
dc.subject | Clinical Biochemistry | |
dc.subject | Cancer Research | |
dc.subject | Pharmacology | |
dc.title | Contribution and Value of Biomarkers in Acute Aortic Syndromes | |
dc.type | Makale | |
dc.relation.journal | CURRENT PHARMACEUTICAL BIOTECHNOLOGY | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 18 | |
dc.identifier.issue | 6 | |
dc.identifier.startpage | 495 | |
dc.identifier.endpage | 498 | |
dc.contributor.firstauthorID | 238522 | |